A client with immune thrombocytopenic purpura (ITP) will begin treatment with romiplostim (Nplate) to be administered by subcutaneous injection in the provider's office once per week. Which statement should the nurse plan to include when educating the client about this medication?
This medication increases the production of plasma enzyme ADAMTS-13.
This medication prevents platelets from being destroyed in the spleen.
This medication prevents platelets from binding with heparin.
This medication stimulates the bone marrow to increase platelet production.
The Correct Answer is D
A. Romiplostim does not increase the production of ADAMTS-13; it is used to increase platelet counts.
B. Romiplostim does not prevent platelet destruction in the spleen; it works by stimulating platelet production.
C. Romiplostim does not prevent platelets from binding with heparin; it is not used for heparin-induced thrombocytopenia.
D. Romiplostim is a thrombopoietin receptor agonist that stimulates the bone marrow to increase platelet production, which is its primary mechanism of action in treating ITP.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["24"]
Explanation
To calculate the IV pump rate, you'll need to use the formula: (Ordered amount of medication (units/hr) × Volume of fluid in mL) / Amount of medication in the volume = IV pump rate in mL/hr. For the given scenario, the ordered amount is 1,200 units/hr, the volume of fluid is 500 mL, and the amount of medication in the volume is 25,000 units. Plugging these numbers into the formula gives you: (1,200 units/hr × 500 mL) / 25,000 units = 24 mL/hr. Therefore, the nurse should set the IV pump to deliver 24 mL/hr.
Correct Answer is D
Explanation
A. Heart transplantation is not indicated for atrial flutter; it is reserved for end-stage heart failure or severe cardiac conditions that cannot be managed by other means.
B. Defibrillation is used in emergency situations for life-threatening arrhythmias like ventricular fibrillation, not for atrial flutter.
C. Coronary artery stent placement is used to open blocked coronary arteries, not to treat arrhythmias.
D. Radiofrequency catheter ablation targets and destroys the abnormal conduction pathways causing atrial flutter, providing a more permanent solution when medications are ineffective.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
